Latest Insider Transactions at Bausch Health Companies Inc. (BHC)
This section provides a real-time view of insider transactions for Bausch Health Companies Inc. (BHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch Health Companies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch Health Companies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
440
-0.1%
|
$3,520
$8.35 P/Share
|
|
Nov 29
2024
|
Seana Carson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-0.39%
|
$13,536
$8.37 P/Share
|
|
Sep 30
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,659
+2.86%
|
$61,272
$8.16 P/Share
|
|
Sep 30
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,059
+2.59%
|
$32,472
$8.16 P/Share
|
|
Sep 30
2024
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
842
+0.4%
|
$6,736
$8.16 P/Share
|
|
Sep 06
2024
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
13,370
-2.98%
|
$80,220
$6.21 P/Share
|
|
Sep 05
2024
|
Seana Carson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
51,337
-10.27%
|
$308,022
$6.19 P/Share
|
|
Sep 05
2024
|
John S Barresi SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,982
-2.58%
|
$23,892
$6.19 P/Share
|
|
Aug 30
2024
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,683
-1.07%
|
$73,415
$5.93 P/Share
|
|
Aug 19
2024
|
Jean Jacques Charhon EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
298,838
+50.0%
|
-
|
|
Jul 18
2024
|
John S Barresi SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
49,254
+24.19%
|
-
|
|
Jul 15
2024
|
Aimee J. Lenar EVP, US Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
144,352
+50.0%
|
-
|
|
Jun 28
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,967
+3.43%
|
$53,802
$6.97 P/Share
|
|
Jun 28
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,752
+3.1%
|
$28,512
$6.97 P/Share
|
|
Jun 28
2024
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
986
+0.48%
|
$5,916
$6.97 P/Share
|
|
Jun 20
2024
|
John S Barresi SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,930
-1.8%
|
$11,580
$6.73 P/Share
|
|
May 17
2024
|
Christian A Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+50.0%
|
-
|
|
May 17
2024
|
Frank D. Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+50.0%
|
-
|
|
May 17
2024
|
Robert N Power Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+15.0%
|
-
|
|
May 17
2024
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+14.7%
|
-
|
|
May 17
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+12.67%
|
-
|
|
May 17
2024
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+16.27%
|
-
|
|
May 17
2024
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+16.82%
|
-
|
|
May 17
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,360
+19.73%
|
-
|
|
Mar 29
2024
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,945
+1.29%
|
$29,450
$10.61 P/Share
|
|
Mar 29
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,122
+2.8%
|
$31,220
$10.61 P/Share
|
|
Mar 29
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,890
+2.75%
|
$58,900
$10.61 P/Share
|
|
Mar 29
2024
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
647
+0.38%
|
$6,470
$10.61 P/Share
|
|
Mar 04
2024
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
6,313
-0.31%
|
$56,817
$9.8 P/Share
|
|
Mar 01
2024
|
John S Barresi SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,188
-2.89%
|
$28,692
$9.89 P/Share
|
|
Mar 01
2024
|
Seana Carson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
24,243
-1.15%
|
$218,187
$9.89 P/Share
|
|
Mar 01
2024
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
116,982
-2.0%
|
$1,052,838
$9.89 P/Share
|
|
Feb 29
2024
|
John S Barresi SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
39,126
+26.19%
|
-
|
|
Feb 29
2024
|
Seana Carson EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
147,536
+21.76%
|
-
|
|
Feb 29
2024
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
519,328
+25.89%
|
-
|
|
Dec 29
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,896
+1.72%
|
$31,168
$8.02 P/Share
|
|
Dec 29
2023
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
857
+0.5%
|
$6,856
$8.02 P/Share
|
|
Dec 29
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,793
+3.71%
|
$62,344
$8.02 P/Share
|
|
Dec 29
2023
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,130
+3.77%
|
$33,040
$8.02 P/Share
|
|
Dec 05
2023
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
220
-0.06%
|
$1,540
$7.38 P/Share
|
|
Dec 01
2023
|
Seana Carson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,691
-0.44%
|
$11,837
$7.36 P/Share
|
|
Nov 06
2023
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
43
-0.01%
|
$301
$7.61 P/Share
|
|
Nov 03
2023
|
Seana Carson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.09%
|
$2,338
$7.57 P/Share
|
|
Sep 29
2023
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,029
+3.83%
|
$32,232
$8.22 P/Share
|
|
Sep 29
2023
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,603
+3.76%
|
$60,824
$8.22 P/Share
|
|
Sep 29
2023
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,801
+1.71%
|
$30,408
$8.22 P/Share
|
|
Sep 29
2023
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
836
+0.49%
|
$6,688
$8.22 P/Share
|
|
Sep 06
2023
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
6,685
-1.71%
|
$53,480
$8.28 P/Share
|
|
Sep 05
2023
|
Tom George Vadaketh EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,948
-7.22%
|
$351,584
$8.35 P/Share
|
|
Sep 05
2023
|
John S Barresi SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,982
-5.3%
|
$31,856
$8.35 P/Share
|